2022 Q1 Form 10-Q Financial Statement

#000149315222013259 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $466.5K $607.7K
YoY Change -23.25%
Cost Of Revenue $1.654M $1.405M
YoY Change 17.73%
Gross Profit -$1.187M -$797.1K
YoY Change 48.96%
Gross Profit Margin -254.56% -131.16%
Selling, General & Admin $460.6K $251.0K
YoY Change 83.46%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $424.0K $0.00
YoY Change
% of Gross Profit
Operating Expenses $460.5K $251.1K
YoY Change 83.45%
Operating Profit -$1.648M -$1.048M
YoY Change 57.22%
Interest Expense -$1.446M $1.085M
YoY Change -233.25%
% of Operating Profit
Other Income/Expense, Net $311.8K
YoY Change
Pretax Income -$2.782M $312.6K
YoY Change -990.09%
Income Tax
% Of Pretax Income
Net Earnings -$2.782M $312.6K
YoY Change -990.09%
Net Earnings / Revenue -596.45% 51.43%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$188.5K $11.72K
COMMON SHARES
Basic Shares Outstanding 16.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.903M $19.72K
YoY Change 14619.47%
Cash & Equivalents $56.00K $19.72K
Short-Term Investments $2.847M
Other Short-Term Assets $233.6K $10.56K
YoY Change 2112.22%
Inventory $4.325M $10.71K
Prepaid Expenses
Receivables $162.6K
Other Receivables $500.0K
Total Short-Term Assets $8.124M $40.99K
YoY Change 19718.71%
LONG-TERM ASSETS
Property, Plant & Equipment $12.05M $17.07K
YoY Change 70499.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $14.29M $17.07K
YoY Change 83591.33%
TOTAL ASSETS
Total Short-Term Assets $8.124M $40.99K
Total Long-Term Assets $14.29M $17.07K
Total Assets $22.41M $58.06K
YoY Change 38497.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.151M $1.895M
YoY Change 13.49%
Accrued Expenses $1.741M $900.9K
YoY Change 93.21%
Deferred Revenue
YoY Change
Short-Term Debt $7.666M $135.5K
YoY Change 5556.43%
Long-Term Debt Due $230.3K
YoY Change
Total Short-Term Liabilities $11.56M $3.412M
YoY Change 238.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $205.2K
YoY Change -100.0%
Other Long-Term Liabilities $6.672M
YoY Change
Total Long-Term Liabilities $6.672M $205.2K
YoY Change 3151.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.56M $3.412M
Total Long-Term Liabilities $6.672M $205.2K
Total Liabilities $18.23M $1.599M
YoY Change 1039.93%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.181M $7.079M
YoY Change
Total Liabilities & Shareholders Equity $22.41M $58.06K
YoY Change 38497.66%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$2.782M $312.6K
YoY Change -990.09%
Depreciation, Depletion And Amortization $424.0K $0.00
YoY Change
Cash From Operating Activities -$436.0K -$25.42K
YoY Change 1615.34%
INVESTING ACTIVITIES
Capital Expenditures -$9.730K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$9.730K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 482.0K 20.00K
YoY Change 2309.95%
NET CHANGE
Cash From Operating Activities -436.0K -25.42K
Cash From Investing Activities -9.730K 0.000
Cash From Financing Activities 482.0K 20.00K
Net Change In Cash 36.22K -5.420K
YoY Change -768.27%
FREE CASH FLOW
Cash From Operating Activities -$436.0K -$25.42K
Capital Expenditures -$9.730K
Free Cash Flow -$426.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 EXDID Share Based Compensation Arrangement By Share Based Payment Award Non Option Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2022Q1 EXDID Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercised In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
CY2022Q1 EXDID Share Based Compensation Arrangement By Share Based Payment Award Non Option Forfeited Or Expired In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodWeightedAverageExercisePrice
CY2022Q1 EXDID Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding
USD
CY2022Q1 EXDID Share Based Compensation Arrangement By Share Based Payment Award Non Option Vested And Exercisable In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionVestedAndExercisableInPeriodWeightedAverageIntrinsicValue
CY2021Q1 EXDID Employer Retention Credit
EmployerRetentionCredit
USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
CY2022Q1 EXDID Gain On Forgiveness Of Debt
GainOnForgivenessOfDebt
USD
CY2022Q1 EXDID Proceeds From Payroll Protection Loan Related Party
ProceedsFromPayrollProtectionLoanRelatedParty
USD
CY2021Q1 EXDID Conversion Of Preferred Shares To Note Payable
ConversionOfPreferredSharesToNotePayable
USD
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q4 EXDID Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding
USD

Files In Submission

Name View Source Status
0001493152-22-013259-index-headers.html Edgar Link pending
0001493152-22-013259-index.html Edgar Link pending
0001493152-22-013259.txt Edgar Link pending
0001493152-22-013259-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
exdid-20220331.xsd Edgar Link pending
exdid-20220331_cal.xml Edgar Link unprocessable
exdid-20220331_def.xml Edgar Link unprocessable
exdid-20220331_lab.xml Edgar Link unprocessable
exdid-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending